Literature DB >> 11384102

Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray.

J H Bull1, G Ellison, A Patel, G Muir, M Walker, M Underwood, F Khan, L Paskins.   

Abstract

The identification of novel genes or groups of genes expressed in prostate cancer may allow earlier diagnosis or more accurate staging of the disease. We describe the assembly and use of a 1877-member microarray representing cDNA clones from a range of prostate cancer stages and grades, precursor lesions and normal tissue. Using labelled cDNA from tumour samples obtained from TURP or radical prostatectomy, analysis of expression patterns identified many up-regulated transcripts. Cell lines were found to over-express fewer genes than diseased tissue samples. 17 known genes were found to over-express more than 4-fold in 4 or more cancers out of 15 cancers. Only 2 genes were over-expressed in 6 out of 15 cancers or more, whilst no genes were consistently found to be over-expressed in all cancer samples. Novel prostate cancer associations for several well characterized genes or full length cDNAs were identified, including PLRP1, JM27, human UbcM2, dynein light intermediate chain 2 and human homologue of rat sec61. Novel associations with high-grade PIN include: breast carcinoma fatty acid synthase and cDNA DKFZp434B0335. We shortlist and discuss the most significant over-expressed genes in prostate cancer and PIN, and highlight expression differences between malignant and benign samples. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384102      PMCID: PMC2363654          DOI: 10.1054/bjoc.2001.1816

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  41 in total

1.  Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes.

Authors:  M G Walker; W Volkmuth; E Sprinzak; D Hodgson; T Klingler
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

2.  Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production.

Authors:  A J da Silva; Z Li; C de Vera; E Canto; P Findell; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues.

Authors:  M J Häggman; J A Macoska; K J Wojno; J E Oesterling
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

4.  Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC, and RANTES.

Authors:  H Nomiyama; S Fukuda; M Iio; S Tanase; R Miura; O Yoshie
Journal:  J Interferon Cytokine Res       Date:  1999-03       Impact factor: 2.607

5.  Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.

Authors:  K Wang; L Gan; E Jeffery; M Gayle; A M Gown; M Skelly; P S Nelson; W V Ng; M Schummer; L Hood; J Mulligan
Journal:  Gene       Date:  1999-03-18       Impact factor: 3.688

6.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays.

Authors:  U Alon; N Barkai; D A Notterman; K Gish; S Ybarra; D Mack; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

7.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

8.  Structure and transcription regulation of the human insulin-like growth factor binding protein 4 gene (IGFBP4).

Authors:  H Zazzi; A Nikoshkov; K Hall; H Luthman
Journal:  Genomics       Date:  1998-05-01       Impact factor: 5.736

9.  CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.

Authors:  J D Brooks; M Weinstein; X Lin; Y Sun; S S Pin; G S Bova; J I Epstein; W B Isaacs; W G Nelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-06       Impact factor: 4.254

10.  The 58-kDa microspherule protein (MSP58), a nucleolar protein, interacts with nucleolar protein p120.

Authors:  Y Ren; R K Busch; L Perlaky; H Busch
Journal:  Eur J Biochem       Date:  1998-05-01
View more
  30 in total

1.  A novel sensitive microarray approach for differential screening using probes labelled with two different radioelements.

Authors:  H Salin; T Vujasinovic; A Mazurie; S Maitrejean; C Menini; J Mallet; S Dumas
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

Review 3.  Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Authors:  Ming-hui Li; Sheng-bo Fu; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

4.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 5.  Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.

Authors:  Giorgio Gorini; Richard L Bell; R Dayne Mayfield
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  LSOSS: Detection of Cancer Outlier Differential Gene Expression.

Authors:  Yupeng Wang; Romdhane Rekaya
Journal:  Biomark Insights       Date:  2010-08-05

7.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

Review 8.  Biomarkers for benign prostatic hyperplasia progression.

Authors:  Grant W Cannon; Robert H Getzenberg
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

9.  Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.

Authors:  Xiaoming Ju; Adam Ertel; Mathew C Casimiro; Zuoren Yu; Hui Meng; Peter A McCue; Rhonda Walters; Paolo Fortina; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

Review 10.  [Microarrays].

Authors:  M-O Grimm; F H Hartmann; W A Schulz
Journal:  Urologe A       Date:  2004-06       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.